Global Human Mesenchymal Stem Cells (hMSC) Market Growth (Status and Outlook) 2025-2031

According to this study, the global Human Mesenchymal Stem Cells (hMSC) market size will reach US$ 161 million by 2031.

Human mesenchymal stem cells (hMSC) are multipotent stromal cells that can differentiate into a variety of cell types.

United States market for Human Mesenchymal Stem Cells (hMSC) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Human Mesenchymal Stem Cells (hMSC) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Human Mesenchymal Stem Cells (hMSC) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Human Mesenchymal Stem Cells (hMSC) players cover PromoCell, ThermoFisher, KURABO, Lifeline Cell Technology, Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Human Mesenchymal Stem Cells (hMSC) Industry Forecast” looks at past sales and reviews total world Human Mesenchymal Stem Cells (hMSC) sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Mesenchymal Stem Cells (hMSC) sales for 2025 through 2031. With Human Mesenchymal Stem Cells (hMSC) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Mesenchymal Stem Cells (hMSC) industry.

This Insight Report provides a comprehensive analysis of the global Human Mesenchymal Stem Cells (hMSC) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Mesenchymal Stem Cells (hMSC) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Mesenchymal Stem Cells (hMSC) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Mesenchymal Stem Cells (hMSC) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Mesenchymal Stem Cells (hMSC).

This report presents a comprehensive overview, market shares, and growth opportunities of Human Mesenchymal Stem Cells (hMSC) market by product type, application, key players and key regions and countries.

Segmentation by Type:
Umbilical Cord Matrix hMSC
Bone Marrow hMSC
Adipose Tissue hMSC
Other

Segmentation by Application:
Medical Application
Research
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
PromoCell
ThermoFisher
KURABO
Lifeline Cell Technology
Merck

Please note: The report will take approximately 2 business days to prepare and deliver. Show more